Search Results for 'Dtg-Hiv'

Dtg-Hiv published presentations and documents on DocSlides.

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

by iris

ADVANCE. . Design. Primary endpoint. Proportion ...

DTG + 3TC versus DTG + TDF-FTC as Initial ART

DTG + 3TC versus DTG + TDF-FTC as Initial ART

by della

GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

by kylo

Andrew Hill, Francois Venter, Eric . Delaporte. , ...

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials

by luanne-stotts

Progressive rises in weight and clinical obesity ...

DTG/3TC 1st line (GEMINI)

DTG/3TC 1st line (GEMINI)

by oryan

ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

by jacey

1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

by jasmine

–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...

Updates on Individual and Universal HIV Treatment Strategies

Updates on Individual and Universal HIV Treatment Strategies

by norah

EECA INTERACT, November 19, 2019. Stefan Baral, MD...

Basic HIV Course for Health Professionals

Basic HIV Course for Health Professionals

by megan

Session 12: Contraceptives and HIV. Learning Objec...

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

by brown

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

Heather Watts MD Director of HIV Prevention, Program Quality Team

Heather Watts MD Director of HIV Prevention, Program Quality Team

by alida-meadow

Heather Watts MD Director of HIV Prevention, Pro...

10 th International Pediatric HIV Workshop

10 th International Pediatric HIV Workshop

by faustina-dinatale

and 22. nd. International AIDS Conference . Sele...

Potential safety issue affecting women living with HIV using

Potential safety issue affecting women living with HIV using

by luanne-stotts

dolutegravir. at the time of conception. Meg Doh...

10 th International Pediatric HIV Workshop

10 th International Pediatric HIV Workshop

by luanne-stotts

and 22. nd. International AIDS Conference . Sele...

DTG vs LPV/r (DAWNING): Efficacy

DTG vs LPV/r (DAWNING): Efficacy

by winnie

by Baseline NRTI Resistance . and Second-Line NRTI...

Switch to DTG/3TC TANGO Design

Switch to DTG/3TC TANGO Design

by lam

Endpoints. Primary: proportion of patients with HI...

Superior Efficacy of Dolutegravir (DTG) Plus

Superior Efficacy of Dolutegravir (DTG) Plus

by celsa-spraggs

2 Nucleoside Reverse Transcriptase Inhibitors (NR...

Switch to DTG/ABC/3TC

Switch to DTG/ABC/3TC

by karlyn-bohler

STRIIVING . Study. Design. Endpoints. Primary: pr...

DTG-Based Regimens Are Active in INI-Naive Patients With a

DTG-Based Regimens Are Active in INI-Naive Patients With a

by trish-goza

Jim Demarest. ,. 1. Mark Underwood,. 2. Marty S...

Antiretrovirals for prevention in women of childbearing age:

Antiretrovirals for prevention in women of childbearing age:

by tremblay

issues to consider. Landon Myer. We all have “is...

Optimization of Antiretroviral Therapy

Optimization of Antiretroviral Therapy

by belinda

With Emergence of Comorbidities. Roger J. . Bedimo...

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

by deena

Pedro Cahn. Disclosures. Advisory. . boards. : Me...

Challenging Cases in Antiretroviral Therapy and Panel Discussion

Challenging Cases in Antiretroviral Therapy and Panel Discussion

by gagnon

Paul E. Sax, MD. Professor of Medicine. Harvard Me...

What’s new in the 2019 WHO Guidelines:

What’s new in the 2019 WHO Guidelines:

by elina

Dolutegravir based regimens in first- ad second-li...

HIV History successes and lessons learned

HIV History successes and lessons learned

by linda

PADO-Dr Martina Penazzato MD MSc PhDPaediatricHIV ...

The SA National PMTCT Guidelines (2019)

The SA National PMTCT Guidelines (2019)

by cleminal

Outline. The ideal PMTCT pathway . Detail of new i...

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.

by liane-varnes

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. ...

Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications

Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications

by liane-varnes

July 24 2018 . Overview on Safety of HIV Treatmen...

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

by myesha-ticknor

Martina Penazzato MD, PhD. Paediatric lead, HIV D...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

by conchita-marotz

FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...

HIV/AIDS HIV There are two types of HIV virus HIV 1 and HIV 2 ,most cases are caused by type 1 ,t

HIV/AIDS HIV There are two types of HIV virus HIV 1 and HIV 2 ,most cases are caused by type 1 ,t

by phoebe

HIV1 and slower to progress to AIDS.. Most cases a...

Emergence of resistance in

Emergence of resistance in

by emma

HIV-1 Integrase . following dolutegravir (DTG) tre...

Dolutegravir-Lamivudine (

Dolutegravir-Lamivudine (

by audrey

Dovato. ). Last Updated: November 28, 2022. Prepar...

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents

by ethlyn

Linda Barlow-Mosha*. 1. , Grace Miriam . Ahimbisib...

Meg Doherty MD MPH PhD 23 July 2018

Meg Doherty MD MPH PhD 23 July 2018

by jordyn

WHO HQ. The role of DTG based regimens in first- a...

Comparison of INSTI vs INSTI

Comparison of INSTI vs INSTI

by mediumgeneral

QDMRK. SPRING-2. ONCEMRK. GS-US-380-1489. GS-US-38...

Comparison of INSTI vs EFV

Comparison of INSTI vs EFV

by mediumgeneral

STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...

What’s New in WHO Treatment Guidelines

What’s New in WHO Treatment Guidelines

by aaron

July 23 2018 . What We Know About Safety Signals ...

1 Queen Mary University, London, United Kingdom;

1 Queen Mary University, London, United Kingdom;

by trish-goza

1 Queen Mary University, London, United Kingdom; ...

Dolutegravir monotherapy

Dolutegravir monotherapy

by alexa-scheidler

Dolutegravir monotherapy vs. dolutegravir/ abac...